subject: UMLS:C4733514

subject_name: BLEX 404

object_name: pancreatic neoplasm


subject: UMLS:C4733514

object_name: exocrine pancreatic carcinoma

tested_intervention: yes


subject: UMLS:C4733514

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Arthritis of first carpometacarpal joint of left hand


subject: PUBCHEM.COMPOUND:5281767

object_name: Arthritis of first carpometacarpal joint of right hand


subject: DRUGBANK:DB19193

object_name: prostate cancer


subject: DRUGBANK:DB19193

object_name: prostate neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109093

subject_name: EPOETIN DELTA

object_name: kidney failure

tested_intervention: unsure


subject: UMLS:C1873342

subject_name: epoetin delta


subject: CHEBI:58097

object_name: choanal atresia


subject: CHEBI:58097

object_name: primary cutaneous amyloidosis


subject: CHEBI:58097

object_name: posterior cortical atrophy


subject: CHEBI:58097

object_name: amyloidosis, primary localized cutaneous, 1


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: non-secretory plasma cell myeloma


subject: PUBCHEM.COMPOUND:73005958

object_name: Plasmacytosis


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:28364

subject_name: Icosapent

object_name: Dyskinesia


subject: PUBCHEM.COMPOUND:56841665

subject_name: CAV regimen

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:56841665

object_name: acute myeloid leukemia


subject: CHEBI:31431

object_name: plasma cell myeloma


subject: CHEBI:173763

subject_name: Thermophillin


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: UNII:W6YJ85G6YG

subject_name: TONLAMARSEN

object_name: hypertension


subject: UNII:W6YJ85G6YG

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Pregnant


subject: PUBCHEM.COMPOUND:521372

object_name: pregnancy disorder


subject: PUBCHEM.COMPOUND:521372

object_name: Adverse Birth Outcomes


subject: CHEBI:46081

subject_name: Fluconazole

object_name: Fungal retinitis


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Femur fracture


subject: CHEBI:33380

subject_name: thulium atom

object_name: Burn injury


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: UMLS:C3166394

subject_name: Tm antigen


subject: PR:000002105

subject_name: thrombomodulin


subject: UMLS:C0114346

subject_name: Dimesna

object_name: cervical intraepithelial neoplasia


subject: UMLS:C0114346

object_name: dysplasia of cervix


subject: CHEBI:50182

subject_name: ARUNDINE


subject: CHEBI:50182


subject: UMLS:C4723695

subject_name: penpulimab

object_name: cervical cancer


subject: UMLS:C4723695

object_name: cervical carcinoma


subject: CHEBI:170007

subject_name: Nirmatrelvir

object_name: Chronic uremia


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: neoplasm


subject: UNII:CWG62Q1VTB

object_name: Tumor Mass


subject: UMLS:C1511563

subject_name: Curcumin C3 Complex

object_name: cervical polyp


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: myocardial ischemia


subject: CHEBI:9130

object_name: coronary atherosclerosis


subject: UMLS:C4733692

subject_name: Ialuril Soft Gels

object_name: prostate carcinoma


subject: UMLS:C4733692

object_name: prostate cancer


subject: UMLS:C4331414

subject_name: timolumab

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: pulpitis


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C4546942

object_name: Injury due to exposure to external cause


subject: UMLS:C4546942

object_name: Exposure history


subject: UNII:TN7CUD1NGA

object_name: Hepatic impairment


subject: UMLS:C5667147

subject_name: Tasurgratinib


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: chronic idiopathic urticaria


subject: PUBCHEM.COMPOUND:40

object_name: common cold


subject: PUBCHEM.COMPOUND:40

object_name: Acute Coryza


subject: CHEBI:84755

subject_name: Deoxyglucose


subject: CHEBI:84755


subject: CHEBI:15866


subject: CHEBI:15866


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: toxic or nutritional optic neuropathy


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UNII:7DR7JMB8BH

object_name: Refractory Ependymoma


subject: UNII:7DR7JMB8BH

object_name: Refractory Soft Tissue Sarcoma


subject: UNII:7DR7JMB8BH

object_name: Recurrent Rhabdomyosarcoma


subject: UNII:7DR7JMB8BH

object_name: Refractory Malignant Glioma


subject: UNII:7DR7JMB8BH

object_name: Recurrent Malignant Glioma


subject: UNII:7DR7JMB8BH

object_name: Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: UNII:7DR7JMB8BH

object_name: Recurrent tumors of the Ewing's family


subject: UNII:7DR7JMB8BH

object_name: Malignant Solid Neoplasm


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: CHEBI:63660

object_name: endometriosis


subject: CHEBI:63618

subject_name: Pravastatin


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Chronic liver disease


subject: CHEMBL.COMPOUND:CHEMBL2109357

subject_name: VELIGROTUG

object_name: euthyroid Graves orbitopathy


subject: CHEMBL.COMPOUND:CHEMBL2109357

object_name: endocrine exophthalmos


subject: UNII:Z9U2SS9ZC8


subject: UNII:Z9U2SS9ZC8


subject: UMLS:C2703165


subject: UMLS:C2703165


subject: UNII:TC549UFL8P

object_name: Fatty Liver


subject: UMLS:C1831848


subject: CHEBI:32139

object_name: Insulin resistance


subject: CHEBI:32139

object_name: Diabetes


subject: CHEBI:32139

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:32139

object_name: Fatigue


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: Well male adult


subject: CHEBI:4445

subject_name: Desflurane

object_name: osteoarthritis


subject: CHEBI:4445

object_name: Dwarfism


subject: CHEBI:4445

object_name: Short stature


subject: CHEBI:4445

object_name: Short Stature, CTCAE


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Sandhoff disease


subject: CHEBI:191174

object_name: Tay-Sachs disease


subject: CHEBI:191174

object_name: GM2 gangliosidosis


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: CHEBI:8673


subject: CHEBI:8673


subject: UMLS:C0876064

subject_name: Lantus

object_name: Surgical procedure finding


subject: CHEBI:30884

subject_name: glycoloyl group

object_name: uterine fibroid


subject: CHEBI:73890

subject_name: Gly-Cys


subject: CHEBI:133047

subject_name: Gly-Phe


subject: UNII:VM36F9N236

subject_name: Cyclosarin


subject: UMLS:C5554934

subject_name: FLT3 Inhibitor XY0206

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5554934

object_name: acute myeloid leukemia


subject: UNII:YW45RY9QD4


subject: UMLS:C0284216


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: UMLS:C5417881

subject_name: Volrustomig


subject: UMLS:C5854526

subject_name: Irinotecan Liposome HR070803

object_name: colorectal cancer


subject: UMLS:C5854526

object_name: colorectal carcinoma


subject: UMLS:C5854526

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Cervical myelopathy


subject: PUBCHEM.COMPOUND:4715169

object_name: Cervical spondylosis without myelopathy


subject: PUBCHEM.COMPOUND:4715169

object_name: Neck Arthritis


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:2904

subject_name: Atenolol

object_name: preeclampsia


subject: CHEBI:2904

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:2904

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:2904

object_name: morbid obesity


subject: CHEBI:167638

subject_name: Labetalol


subject: CHEBI:167638


subject: CHEBI:167638


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:7565


subject: CHEBI:7565


subject: PUBCHEM.COMPOUND:155885731

subject_name: Maribavir

object_name: tyrosinemia type I


subject: UMLS:C2746046

subject_name: sculptra

object_name: Photodamaged skin


subject: CHEBI:60802

subject_name: ropivacaine

object_name: ductal breast carcinoma in situ


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: cardiovascular disorder


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UMLS:C1384585

subject_name: Blood group antigen P2

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1384585

object_name: metabolic syndrome X


subject: CHEBI:74824

subject_name: Thr-Ala


subject: CHEBI:74824


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PUBCHEM.COMPOUND:4532223


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000006886


subject: PR:000016550


subject: PR:000016550


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Streptococcal tonsillitis


subject: UMLS:C0054946

subject_name: CD20 Antigens

object_name: EXCESS LMW-DNA


subject: UMLS:C0054946

object_name: multiple sclerosis


subject: UMLS:C0054946

object_name: myasthenia gravis


subject: UMLS:C0054946

object_name: Myasthenia Gravis, CTCAE


subject: PR:000001289

subject_name: membrane-spanning 4-domains subfamily A member 1


subject: PR:000001289


subject: PR:000001289


subject: PR:000001289


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: appendicitis


subject: CHEBI:74538

object_name: Appendicitis, CTCAE


subject: CHEBI:74538

object_name: Perforation of appendix (disorder)


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C0721277


subject: UMLS:C0721277


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: UMLS:C1832078


subject: UMLS:C1832078


subject: UMLS:C5856419

subject_name: Gallium Ga 68 P3

object_name: neoplasm


subject: CHEBI:31709

subject_name: Iohexol

object_name: Critical Illness


subject: CHEBI:31709

object_name: Augmented renal clearance


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0699319

object_name: Embolism, Tumor


subject: UMLS:C0699319

object_name: Neoplasm Metastasis


subject: CHEBI:27470

subject_name: Folic acid

object_name: hyperhomocysteinemia


subject: CHEBI:27470

object_name: diabetic kidney disease


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: urothelial carcinoma


subject: UMLS:C5557618

subject_name: ATR Inhibitor ATRN-119

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:BE52S2C1QT

subject_name: Abeprazan

object_name: Heartburn


subject: UNII:BE52S2C1QT

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: transplantation infection


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C1134664

object_name: carcinoma of esophagus


subject: UMLS:C1134664

object_name: esophageal cancer


subject: UMLS:C1134664

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C1134664

object_name: neoplasm of esophagus


subject: UMLS:C0541491

subject_name: Drugs and Biologicals

object_name: ulcerative colitis


subject: UMLS:C0541491

object_name: inflammatory bowel disease 1


subject: UMLS:C3641717

subject_name: SUBA-itraconazole

object_name: Basal cell carcinoma in basal cell nevus syndrome


subject: CHEBI:132967

subject_name: Elbasvir

object_name: acute hepatitis C virus infection


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Polycystic ovary syndrome of bilateral ovaries


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin


subject: UMLS:C0025326

subject_name: Menotropins


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23066

subject_name: cephalosporin

object_name: cholecystitis


subject: CHEBI:23066

object_name: acute cholecystitis


subject: CHEMBL.COMPOUND:CHEMBL5482975

subject_name: CEPHALOSPORIN


subject: CHEMBL.COMPOUND:CHEMBL5482975


subject: UMLS:C4706514

subject_name: Cephalosporin product


subject: UMLS:C4706514


subject: CHEBI:8378

subject_name: Prednisolone

object_name: celiac disease


subject: CHEMBL.COMPOUND:CHEMBL2109205

subject_name: nonacog alfa

object_name: hemophilia A


subject: CHEMBL.COMPOUND:CHEMBL2109205

object_name: hemophilia


subject: UMLS:C1619396

subject_name: DEXAMETHASONE, ORAL, 0.25 MG ADMINISTERED

object_name: croup


subject: UMLS:C1619396

object_name: Laryngotracheobronchitis


subject: UMLS:C1619396

object_name: Subglottic laryngitis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:33375

subject_name: Gadolinium

object_name: Non-small cell lung cancer stage III


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: UMLS:C2697997

subject_name: Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C2697997

object_name: breast carcinoma


subject: UMLS:C2697997

object_name: breast cancer


subject: UMLS:C2981846

object_name: squamous cell lung carcinoma


subject: UMLS:C2981846

object_name: triple-negative breast carcinoma


subject: UMLS:C2981846

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:231425

subject_name: tolvaptan

object_name: autosomal recessive polycystic kidney disease


subject: UMLS:C0762110


subject: UMLS:C5241183

subject_name: Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)

object_name: poliomyelitis


subject: CHEBI:33283

subject_name: THIAMINE

object_name: thyrotoxicosis


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: CHEBI:18385

subject_name: Thiamine


subject: GTOPDB:9802

object_name: Graves disease


subject: UMLS:C4548814


subject: UNII:14WE3Z92C4

object_name: influenza


subject: UMLS:C5925658


subject: CHEBI:231683

subject_name: Anakinra

object_name: uveitis


subject: CHEBI:231683

object_name: Uveitis, CTCAE


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: Activating EGFR Gene Mutation


subject: UMLS:C4329594

subject_name: CEA-MUC-1-TRICOM Vaccine CV301

object_name: bladder tumor


subject: UMLS:C4329594

object_name: urinary bladder carcinoma


subject: UMLS:C4329594

object_name: urinary bladder cancer


subject: UMLS:C4329594

object_name: childhood bladder carcinoma


subject: CHEBI:9622

subject_name: Tolterodine

object_name: Mixed urinary incontinence


subject: CHEBI:9622

object_name: urgency urinary incontinence


subject: CHEBI:9622

object_name: Stress urinary incontinence


subject: PUBCHEM.COMPOUND:2269

object_name: periodontal disorder


subject: PUBCHEM.COMPOUND:2269

object_name: Periodontal Disease, CTCAE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732

object_name: periodontitis


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: PUBCHEM.COMPOUND:4134252

subject_name: gluconate

object_name: periodontitis, chronic, adult


subject: PUBCHEM.COMPOUND:4134252

object_name: chronic periodontitis


subject: PUBCHEM.COMPOUND:4134252


subject: PUBCHEM.COMPOUND:4134252


subject: PUBCHEM.COMPOUND:4134252


subject: MESH:D005942

subject_name: Gluconates


subject: MESH:D005942


subject: MESH:D005942


subject: MESH:D005942


subject: MESH:D005942


subject: CHEBI:24265


subject: CHEBI:24265


subject: CHEBI:24265


subject: CHEBI:24265


subject: CHEBI:24265


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: CHEBI:33198


subject: CHEBI:33198


subject: CHEBI:33198


subject: CHEBI:33198


subject: UMLS:C0791514

subject_name: Chlorhexidine Gluconate Solution


subject: UMLS:C0791514


subject: UMLS:C0791514


subject: UMLS:C0791514


subject: UMLS:C0791514


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:23664049


subject: PUBCHEM.COMPOUND:23664049


subject: PUBCHEM.COMPOUND:23664049


subject: PUBCHEM.COMPOUND:23664049


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: angioimmunoblastic T-cell lymphoma


subject: GTOPDB:9592

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: GTOPDB:9592

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: GTOPDB:9592

object_name: primary cutaneous T-cell lymphoma


subject: GTOPDB:9592

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: GTOPDB:9592

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: GTOPDB:9592

object_name: Lymphoma, Extranodal NK-T-Cell


subject: GTOPDB:9592

object_name: Adult Anaplastic Large Cell Lymphoma


subject: GTOPDB:9592

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: GTOPDB:9592

object_name: anaplastic large cell lymphoma


subject: GTOPDB:9592

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: GTOPDB:9592

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: GTOPDB:9592

object_name: ALK-positive anaplastic large cell lymphoma


subject: GTOPDB:9592

object_name: ALK-negative anaplastic large cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: heparin-induced thrombocytopenia


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: urgency urinary incontinence


subject: PUBCHEM.COMPOUND:5284632

subject_name: Trospium


subject: UNII:ZLW14X2D30

object_name: Acquired Hypogammaglobulinemia


subject: UNII:ZLW14X2D30

object_name: severe combined immunodeficiency


subject: UNII:ZLW14X2D30

object_name: Immunodeficiency with predominant T-cell defect, unspecified


subject: UNII:ZLW14X2D30

object_name: chronic granulomatous disease


subject: UNII:ZLW14X2D30

object_name: Mendelian susceptibility to mycobacterial disease


subject: UNII:ZLW14X2D30

object_name: severe congenital neutropenia


subject: UNII:ZLW14X2D30

object_name: Wiskott-Aldrich syndrome


subject: UNII:ZLW14X2D30

object_name: Job Syndrome


subject: UMLS:C0108779

subject_name: CD3 Antigens


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: UMLS:C0108779


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: adult hepatocellular carcinoma


subject: CHEBI:36939

object_name: Carcinoma liver resectable


subject: CHEBI:36939

object_name: cholangiocarcinoma


subject: CHEBI:36939

object_name: Benign neoplasm of liver


subject: CHEBI:36939

object_name: Metastatic malignant neoplasm to liver


subject: PUBCHEM.COMPOUND:10352692

subject_name: Fluoro-d-glucose


subject: PUBCHEM.COMPOUND:10352692


subject: PUBCHEM.COMPOUND:10352692


subject: PUBCHEM.COMPOUND:10352692


subject: PUBCHEM.COMPOUND:10352692


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: HER2 positive


subject: CHEBI:16646

subject_name: carbohydrate

object_name: Post-Operative Pain


subject: CHEBI:16646

object_name: outcomes general quality of life


subject: CHEBI:16646

object_name: Perceived quality of life


subject: CHEBI:16646

object_name: Good quality of life


subject: CHEBI:16646

object_name: Postoperative Nausea


subject: CHEBI:16646

object_name: Breastfeeding (mother)


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Pediatric Disorder


subject: UNII:1C6V77QF41

object_name: congenital heart disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:50733

subject_name: nutraceutical

object_name: schizophrenia


subject: CHEBI:50733

object_name: schizoaffective disorder


subject: CHEBI:50733

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Relapsed/refractory multiple myeloma


subject: UMLS:C1709429


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX


subject: UNII:30R67U9KYS


subject: PR:000010252

object_name: alcoholic hepatitis


subject: PR:000010252

object_name: alcoholic fatty liver disease


subject: UNII:17VAN37K4Y

object_name: endogenous depression


subject: UNII:17VAN37K4Y

object_name: major depressive disorder


subject: CHEBI:85503

object_name: Sepsis


subject: CHEBI:85503

object_name: Sepsis, CTCAE


subject: CHEBI:85503

object_name: septic shock


subject: UMLS:C0939261

subject_name: B-Complex


subject: UMLS:C0939261


subject: UMLS:C0939261


subject: UMLS:C1588750

subject_name: Complex B


subject: UMLS:C1588750


subject: UMLS:C1588750


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: primary hyperparathyroidism


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:31348

subject_name: Capecitabine

object_name: gastric cardia carcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:142406

subject_name: ziconotide

object_name: HIV infection


subject: PUBCHEM.COMPOUND:16135415

subject_name: Ziconotide


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: hypertension


subject: CHEBI:49040

object_name: Hypertension, CTCAE


subject: UNII:TUP7882K8T

subject_name: DCFBC F-18

object_name: prostate carcinoma


subject: UNII:TUP7882K8T

object_name: prostate cancer


subject: UNII:TUP7882K8T

object_name: prostate neoplasm


subject: UMLS:C2604127


subject: CHEBI:26708

subject_name: sodium atom


subject: CHEBI:26708


subject: CHEBI:26708


subject: CHEBI:29101

subject_name: Sodium cation


subject: CHEBI:29101


subject: CHEBI:29101


subject: UMLS:C3541959

subject_name: Sodium supplements


subject: UMLS:C3541959


subject: UMLS:C3541959


subject: UMLS:C3714642

subject_name: Sodium Drug Class


subject: UMLS:C3714642


subject: UMLS:C3714642


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS

object_name: oral candidiasis


subject: UMLS:C3273718

subject_name: Maveropepimut-S

object_name: malignant epithelial tumor of ovary


subject: UMLS:C2985188

object_name: neoplasm


subject: UMLS:C0877799

subject_name: pickle, CHD3 chromatin-remodeling factor

object_name: Craving


subject: CHEMBL.COMPOUND:CHEMBL2108554

subject_name: PEPPERMINT WATER

object_name: breast disorder


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Reperfusion Injury


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: hepatitis C


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UMLS:C4508859

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C4508859

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C4508859

object_name: pulmonary arterial hypertension


subject: UMLS:C5706475

subject_name: Anti-CLDN6 ADC DS-9606

object_name: Advanced cancer


subject: UMLS:C5706475

object_name: adult germ cell tumor


subject: UMLS:C5706475

object_name: germ cell tumor


subject: UMLS:C5706475

object_name: childhood germ cell tumor


subject: UMLS:C5706475

object_name: Germ Cell Cancer


subject: UMLS:C5706475

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5706475

object_name: Embolism, Tumor


subject: UMLS:C5706475

object_name: Neoplasm Metastasis


subject: CHEBI:27953

subject_name: Physostigmine

object_name: post operative nausea and vomiting


subject: UNII:DGN7ROZ8EN

object_name: Alzheimer disease type 1


subject: UNII:DGN7ROZ8EN

object_name: Alzheimer disease


subject: UMLS:C4722674

subject_name: Vibecotamab

object_name: CD4+/CD56+ hematodermic neoplasm


subject: UMLS:C4722674

object_name: acute myeloid leukemia


subject: UMLS:C4722674

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C4722674

object_name: B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:118224238

object_name: anemia


subject: PUBCHEM.COMPOUND:118224238

object_name: Anemia, CTCAE


subject: CHEBI:91090

subject_name: charcoal

object_name: multiple sclerosis


subject: CHEBI:27594

subject_name: Graphite


subject: PUBCHEM.COMPOUND:193895

subject_name: cyclic adenosine-5'-trimetaphosphate

object_name: recessive dystrophic epidermolysis bullosa


subject: DRUGBANK:DB06108

object_name: liver carcinoma


subject: CHEBI:5100

subject_name: Flucytosine


subject: MESH:D000090983

subject_name: 2019-nCoV Vaccine mRNA-1273

object_name: Vaccine response impaired


subject: MESH:D000090983

object_name: kidney disorder


subject: UMLS:C0359019

subject_name: hydrocortisone / lidocaine

object_name: de Quervain syndrome


subject: CHEBI:16335

subject_name: Adenosine

object_name: coronary stenosis


subject: UMLS:C5222443

subject_name: Fulvestrant Injection

object_name: Advanced breast cancer


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: leukemia


subject: CHEBI:39548

object_name: childhood leukemia


subject: CHEBI:7465

subject_name: Naltrexone

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:47781

subject_name: Desipramine

object_name: post-traumatic stress disorder


subject: CHEBI:47781


subject: CHEBI:47781

object_name: alcohol abuse


subject: CHEBI:47781

object_name: alcohol dependence


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: AIDS


subject: CHEBI:71255

subject_name: Asenapine

object_name: treatment-refractory schizophrenia


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: UMLS:C0701056

subject_name: Clopixol


subject: CHEBI:51364

subject_name: Zuclopenthixol


subject: CHEBI:35474

subject_name: anxiolytic drug


subject: UMLS:C0040616

subject_name: Anti-Anxiety Agents


subject: UMLS:C4722091

subject_name: Anxiolytics [TC]


subject: CHEBI:3756

subject_name: Clonazepam


subject: UMLS:C2987458

subject_name: Seropram


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL


subject: UMLS:C1452088

subject_name: Tavor


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:30145

subject_name: lithium atom


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C0700661

subject_name: Depakene


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C5962732

subject_name: RNR Inhibitor BBI-825

object_name: Childhood Solid Neoplasm


subject: UMLS:C5962732

object_name: Adult Solid Neoplasm


subject: UMLS:C5962732

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:13633150

subject_name: Methyl prednisolonate

object_name: no feeling or sensation of skin


subject: PUBCHEM.COMPOUND:13633150

object_name: Sensory Loss


subject: UMLS:C4045849

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C4045849

object_name: COPD, severe early onset


subject: UMLS:C0302908

subject_name: Liquid substance

object_name: type 2 diabetes mellitus


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: liver carcinoma


subject: MESH:D006495

object_name: Klatskin Tumor


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Thermal burn


subject: GTOPDB:11097

subject_name: efineptakin alfa

object_name: Kaposi Sarcoma


subject: GTOPDB:11097

object_name: HIV infection


subject: CHEMBL.COMPOUND:CHEMBL4594590

subject_name: EFINEPTAKIN ALFA


subject: CHEMBL.COMPOUND:CHEMBL4594590


subject: UMLS:C3714111


subject: UMLS:C3714111


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: status asthmaticus


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: respiratory tract infectious disorder


subject: CHEMBL.COMPOUND:CHEMBL4297728

subject_name: CIRMTUZUMAB

object_name: marginal zone lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297728

object_name: MALT lymphoma


subject: UMLS:C3896753


subject: UMLS:C3896753


subject: CHEBI:73611

subject_name: Met-Gly

object_name: mantle cell lymphoma


subject: CHEBI:73611

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:73611


subject: CHEBI:73611


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: PR:000014976

subject_name: neutral amino acid transporter B(0)


subject: PR:000014976


subject: PR:000014976


subject: PR:000014976


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: Cardiac Events


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban

object_name: Haemorrhagic transformation stroke


subject: DRUGBANK:DB19231

subject_name: Quaratusugene ozeplasmid

object_name: non-small cell lung carcinoma


subject: CHEBI:7627

subject_name: Norethisterone

object_name: bacterial vaginosis


subject: CHEBI:7627


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C2984025

object_name: Fatigue


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Hypothalamic obesity


subject: PUBCHEM.COMPOUND:53477758

object_name: Childhood Craniopharyngioma


subject: PUBCHEM.COMPOUND:53477758

object_name: craniopharyngioma


subject: PUBCHEM.COMPOUND:53477758

object_name: Adult Craniopharyngioma


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C3653473

subject_name: Corticosteroids for local oral treatment

object_name: lichen planus, oral


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Critical Illness


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: fibromyalgia


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:59527

object_name: Inflammation


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:231621

subject_name: Tasisulam

object_name: adult lymphoma


subject: CHEBI:231621

object_name: lymphoma


subject: CHEBI:231621

object_name: pediatric lymphoma


subject: CHEBI:27999

subject_name: Tolbutamide

object_name: Advanced cancer


subject: CHEBI:27999


subject: CHEBI:27999


subject: CHEBI:27999


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Philadelphia Chromosome


subject: CHEBI:41879

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:45783

subject_name: Imatinib

object_name: Blastic Phase


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: Blast Phase


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: acute lymphoblastic leukemia


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Ischemic stroke


subject: CHEBI:85078

object_name: mild neurocognitive disorder


subject: CHEBI:85078

object_name: mild cognitive impairment


subject: CHEBI:85078

object_name: vascular dementia


subject: CHEBI:50858

subject_name: corticosteroid

object_name: sunburn


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: RXCUI:562508

subject_name: amoxicillin 875 MG / clavulanate 125 MG Oral Tablet

object_name: Antibiotic-associated diarrhea


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: pain agnosia


subject: CHEBI:26710

object_name: Pain insensitivity


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: pulmonary eosinophilia


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Disorder of knee


subject: UNII:P5DKZ70636

subject_name: Paxalisib

object_name: glioblastoma


subject: UNII:P5DKZ70636

object_name: Childhood Glioblastoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:404903

subject_name: Ertapenem

object_name: acute kidney failure


subject: UMLS:C5446566

subject_name: B-cell Lymphoma-2 Inhibitor BGB-11417

object_name: mantle cell lymphoma


subject: CHEBI:9241

subject_name: Spironolactone

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:9241

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5238470

subject_name: Pegylated SN-38 Conjugate PLX038

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UMLS:C5238470

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UMLS:C5238470

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C5238470

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C5238470

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5238470

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:2261HH611H

subject_name: Tenalisib

object_name: non-Hodgkin lymphoma


subject: UNII:B4RS1V5YSP

object_name: pulmonary tuberculosis


subject: DRUGBANK:DB18911


subject: UMLS:C1541539

subject_name: Fluorine F 18 EF5

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2742210

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C2742210

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2742210

object_name: Small cell lung cancer extensive stage


subject: UMLS:C2742210

object_name: Small cell lung cancer recurrent


subject: UMLS:C2742210

object_name: HER2 positive


subject: PUBCHEM.COMPOUND:124099

subject_name: metoclopramide sulfone

object_name: Upper gastrointestinal hemorrhage


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:KXG2PJ551I

object_name: B-cell neoplasm


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Advanced cancer


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: Advanced Synovial Sarcoma


subject: UNII:19J3781LPM

object_name: Refractory Synovial Sarcoma


subject: UNII:19J3781LPM

object_name: Metastatic synovial sarcoma


subject: UNII:19J3781LPM

object_name: Chondrosarcoma metastatic


subject: UNII:19J3781LPM

object_name: Metastatic leiomyosarcoma


subject: UNII:19J3781LPM

object_name: Refractory Leiomyosarcoma


subject: UNII:19J3781LPM

object_name: Refractory Myxoid Liposarcoma


subject: UNII:19J3781LPM

object_name: Refractory Soft Tissue Sarcoma


subject: UNII:19J3781LPM

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:19J3781LPM

object_name: Metastatic Soft Tissue Sarcoma


subject: UNII:19J3781LPM

object_name: Advanced Soft Tissue Sarcoma


subject: UNII:19J3781LPM

object_name: Advanced Leiomyosarcoma


subject: UNII:19J3781LPM

object_name: Myxoid liposarcoma metastatic


subject: UNII:19J3781LPM

object_name: Refractory Round Cell Liposarcoma


subject: UNII:19J3781LPM

object_name: Metastatic Round Cell Liposarcoma


subject: UNII:19J3781LPM

object_name: Advanced Myxoid Liposarcoma


subject: UNII:19J3781LPM

object_name: Malignant fibrous histiocytoma metastatic


subject: UNII:19J3781LPM

object_name: Refractory Undifferentiated Pleomorphic Sarcoma


subject: UNII:19J3781LPM

object_name: Advanced Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: myelin oligodendrocyte glycoprotein antibody-associated disease


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: GTOPDB:13316

subject_name: maridebart cafraglutide

object_name: Overweight


subject: UNII:Z24U3U73HN

subject_name: MARIDEBART CAFRAGLUTIDE


subject: UMLS:C5855458

subject_name: Maridebart Cafraglutide


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:63611

object_name: obesity


subject: CHEBI:63611

object_name: Obesity, CTCAE


subject: CHEBI:63611


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Well-differentiated neuroendocrine tumor grade 2 of lung


subject: UNII:MRL3739G66

object_name: Well-differentiated neuroendocrine tumor grade 1 of lung


subject: UNII:MRL3739G66

object_name: Advanced Lung Neuroendocrine Tumor


subject: UNII:MRL3739G66

object_name: Neuroendocrine tumour of the lung metastatic


subject: UNII:MRL3739G66

object_name: lung neuroendocrine neoplasm


subject: UNII:MRL3739G66

object_name: Functioning Lung Neuroendocrine Tumor


subject: UNII:MRL3739G66

object_name: Unresectable Lung Neuroendocrine Tumor


subject: UNII:MRL3739G66

object_name: Locally Advanced Lung Neuroendocrine Neoplasm


subject: UNII:MRL3739G66

object_name: Non-Functioning Lung Neuroendocrine Tumor


subject: UNII:MRL3739G66

object_name: Recurrent Lung Neuroendocrine Neoplasm


subject: UNII:MRL3739G66

object_name: Metastatic Lung Neuroendocrine Neoplasm


subject: UNII:MRL3739G66

object_name: Unresectable Lung Neuroendocrine Neoplasm


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: ductal breast carcinoma in situ


subject: CHEBI:16302

object_name: obstructive sleep apnea syndrome


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:81298

subject_name: beta-muricholic acid

object_name: plasma cell myeloma


subject: CHEBI:6931

subject_name: Midazolam

object_name: hydrocephalus, nonsyndromic, autosomal recessive 1


subject: CHEBI:6931

object_name: hydrocephalus


subject: CHEBI:3757

subject_name: Clonidine

object_name: Other reconstructive surgery


subject: UMLS:C4550007

subject_name: UV1 vaccine

object_name: melanoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: mantle cell lymphoma


subject: CHEBI:61397

subject_name: Neratinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:61397

object_name: Embolism, Tumor


subject: CHEBI:61397

object_name: Neoplasm Metastasis


subject: CHEBI:90881

subject_name: Camptosar

object_name: glioma


subject: UMLS:C4760648


subject: UMLS:C5439909


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Cross Infection


subject: UNII:9U7D5QH5AE


subject: UMLS:C4085973

object_name: Solid Neoplasm


subject: UMLS:C4085973

object_name: gastric cancer


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: progesterone-receptor negative breast cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:177833

subject_name: Cilengitide

object_name: intraocular lymphoma


subject: CHEBI:177833

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:177833

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:177833

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:177833

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:177833

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:177833

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:177833

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:177833

object_name: anaplastic large cell lymphoma


subject: CHEBI:177833

object_name: Mantle cell lymphoma stage III


subject: CHEBI:177833

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:177833

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:177833

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:177833

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:177833

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:177833

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:177833

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:177833

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:177833

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:177833

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:177833

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:177833

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:177833

object_name: splenic marginal zone lymphoma


subject: CHEBI:177833

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:177833

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:177833

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:177833

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:177833

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:177833

object_name: MALT lymphoma


subject: CHEBI:177833

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:177833

object_name: AIDS-related primary central nervous system lymphoma


subject: CHEBI:177833

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:177833

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:177833

object_name: Marginal zone lymphoma stage III


subject: CHEBI:177833

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:177833

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:177833

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:177833

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:177833

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:177833

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:177833

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:177833

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:177833

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:177833

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:177833

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:177833

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:177833

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:177833

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:177833

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:177833

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:177833

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:177833


subject: CHEBI:177833

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:177833

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:177833

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:177833

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:177833

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UMLS:C0764377

object_name: intraocular lymphoma


subject: UMLS:C0764377

object_name: Mantle cell lymphoma stage IV


subject: UMLS:C0764377

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C0764377

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C0764377

object_name: B-cell small lymphocytic lymphoma stage III


subject: UMLS:C0764377

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C0764377

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C0764377

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C0764377

object_name: anaplastic large cell lymphoma


subject: UMLS:C0764377

object_name: Mantle cell lymphoma stage III


subject: UMLS:C0764377

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C0764377

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UMLS:C0764377

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C0764377

object_name: splenic marginal zone lymphoma


subject: UMLS:C0764377

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C0764377

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C0764377

object_name: Marginal zone lymphoma stage IV


subject: UMLS:C0764377

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C0764377

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C0764377

object_name: MALT lymphoma


subject: UMLS:C0764377

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C0764377

object_name: AIDS-related primary central nervous system lymphoma


subject: UMLS:C0764377

object_name: Stage III Adult Hodgkin Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C0764377

object_name: Marginal zone lymphoma stage III


subject: UMLS:C0764377

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C0764377

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C0764377

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0764377

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0764377

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0764377

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0764377

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C0764377

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0764377

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C0764377

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0764377

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0764377

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UMLS:C0764377

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UMLS:C0764377

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C0764377

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0764377


subject: UMLS:C0764377

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0764377

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0764377

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C0764377

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C0764377

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UNII:1PON08459R

subject_name: ajmaline

object_name: Cardiac Death


subject: UNII:1PON08459R

object_name: ventricular fibrillation


subject: UNII:1PON08459R

object_name: Ventricular Fibrillation by ECG Finding


subject: UNII:1PON08459R

object_name: continuous electrocardiogram ventricular fibrillation


subject: UNII:1PON08459R

object_name: Ventricular Fibrillation, CTCAE 3.0


subject: UNII:1PON08459R

object_name: Ventricular Fibrillation, CTCAE 5.0


subject: UNII:1PON08459R

object_name: Channelopathies


subject: PUBCHEM.COMPOUND:2073

subject_name: Aritmina


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: CHEBI:58567

subject_name: ajmalinium


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Conn's syndrome


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:65209

subject_name: Lucitanib

object_name: Carcinoma breast stage IV


subject: CHEBI:65209

object_name: Estrogen Receptor Positive


subject: CHEBI:65209

object_name: HER2 positive


subject: UMLS:C4329319

subject_name: Anti-CSF1 Monoclonal Antibody PD-0360324

object_name: rheumatoid arthritis


subject: UNII:41TIZ5663Z

object_name: Multiple sclerosis relapse


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: laryngeal carcinoma


subject: CHEBI:4466

object_name: larynx cancer


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Critical Illness


subject: CHEBI:40303

subject_name: Lovastatin

object_name: pervasive developmental disorder


subject: CHEBI:40303

object_name: autism


subject: CHEBI:40303

object_name: autism spectrum disorder


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Drug Resistant Epilepsy


subject: CHEBI:188851

subject_name: Muraglitazar

object_name: inherited lipid metabolism disorder


subject: CHEBI:188851

object_name: Dyslipidemia


subject: UMLS:C1568490

subject_name: muraglitazar


subject: UMLS:C1568490


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: UMLS:C3658202

subject_name: Androxal

object_name: Decreased serum testosterone concentration


subject: UMLS:C3658202

object_name: hypogonadism


subject: UNII:J303A6U9Y6

subject_name: ENCLOMIPHENE CITRATE


subject: UNII:J303A6U9Y6


subject: UMLS:C0086214

subject_name: Enclomiphene Citrate


subject: UMLS:C0086214


subject: DRUGBANK:DB11360

subject_name: Lactobacillus plantarum

object_name: psoriasis


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: myotonic dystrophy type 1


subject: CHEBI:135285

object_name: Double Minutes


subject: CHEBI:135285

object_name: dermatomyositis


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Refractory Extensive Stage Lung Small Cell Carcinoma


subject: GTOPDB:8313

object_name: Recurrent Extensive Stage Lung Small Cell Carcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:95341

subject_name: Baricitinib

object_name: type 1 diabetes mellitus 1


subject: CHEBI:95341

object_name: type 1 diabetes mellitus


subject: UMLS:C0358780

subject_name: Allergen extract vaccine

object_name: Atopic rhinitis


subject: UMLS:C0358780

object_name: Allergic Rhinitis, CTCAE


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Sentinel node (disorder)


subject: UMLS:C2987352

subject_name: Nesvacumab

object_name: wet macular degeneration


subject: UMLS:C2987352

object_name: diabetic macular edema


subject: UNII:79R3ZF226Y

object_name: IDH-wildtype glioblastoma


subject: CHEBI:53228


subject: CHEBI:60622


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: vascular: intracranial


subject: CHEBI:172923

object_name: Adult Intracranial Neoplasm


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: chronic graft versus host disease


subject: CHEBI:66910

subject_name: Axitinib

object_name: head and neck squamous cell carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Malignant gastrinoma of pancreas


subject: CHEBI:71219

object_name: Malignant Pancreatic Somatostatinoma


subject: CHEBI:71219

object_name: Glucagonoma, malignant


subject: CHEBI:71219

object_name: Malignant Pancreatic Insulinoma


subject: CHEBI:71219

object_name: recurrent islet cell carcinoma


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C1588339

subject_name: CLOZAPINE (FAZACLO)

object_name: schizophrenia


subject: UMLS:C1588339

object_name: schizoaffective disorder


subject: UMLS:C1588339

object_name: schizophrenia 18


subject: UMLS:C4278839

subject_name: Abcertin

object_name: Gaucher disease


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Breast cancer recurrent


subject: CHEBI:30145

subject_name: lithium atom

object_name: treatment resistant depression


subject: CHEBI:30145


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Heel Spur Syndrome


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Severe Sepsis


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: inflammatory breast carcinoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:27306

subject_name: vitamin B6

object_name: Vomiting, CTCAE


subject: CHEBI:27306

object_name: Vomiting


subject: CHEBI:8871

subject_name: Risperidone

object_name: type 2 diabetes mellitus


subject: CHEBI:8871

object_name: Diabetes


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Infection


subject: CHEBI:35176

object_name: infectious disease


subject: CHEBI:35176

object_name: Adverse Event Associated with Infection


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: Prediabetes


subject: CHEBI:29708

object_name: hyperglycemia


subject: CHEBI:29708

object_name: Hyperglycemia, CTCAE


subject: CHEBI:29708

object_name: Glucose in blood specimen above reference range


subject: UMLS:C3536985

subject_name: gimeracil + oteracil potassium + tegafur

object_name: Stomach cancer


subject: UMLS:C3536985

object_name: gastric cancer


subject: UMLS:C4053649

subject_name: WT1 Protein-derived Peptide Vaccine DSP-7888

object_name: Myelodysplasia


subject: UMLS:C4053649

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C4053649

object_name: childhood myelodysplastic syndrome


subject: UMLS:C4053649

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:E8R04MBQ04

object_name: acute myeloid leukemia by FAB classification


subject: UNII:E8R04MBQ04

object_name: acute myeloid leukemia


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: hand-foot syndrome


subject: CHEBI:192614

object_name: Sickle Cell Dactylitis


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Solid Neoplasm


subject: UMLS:C0963679


subject: PUBCHEM.COMPOUND:134612761

subject_name: macimorelin

object_name: Congenital IGHD


subject: PUBCHEM.COMPOUND:134612761

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C0111046

subject_name: Creon

object_name: type 1 diabetes mellitus


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: Obesity Paradox


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Resectable Head and Neck Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Second Primary Squamous Cell Carcinoma of the Head and Neck


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: Childhood Synovial Sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Adult Synovial Sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: synovial sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: epithelioid sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: adult epithelioid sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: childhood epithelioid sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: undifferentiated pleomorphic sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: hemangioendothelioma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: UMLS:C5435381

object_name: Hashimoto thyroiditis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Hepatocellular Carcinoma


subject: CHEBI:4026

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:3367

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: cancer


subject: CHEBI:173077


subject: PUBCHEM.COMPOUND:135566117

subject_name: Aliqopa


subject: UMLS:C0003308

subject_name: Antifungal Agents

object_name: Immunocompromised Host


subject: UMLS:C0003308

object_name: respiratory failure


subject: UMLS:C0003308

object_name: acute respiratory failure


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Immune System and Related Disorders


subject: PUBCHEM.COMPOUND:521372

object_name: immune system disorder


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: UMLS:C2713112

object_name: Multiple actinic keratoses


subject: CHEBI:80961

object_name: Stomach cancer


subject: CHEBI:80961

object_name: gastric cancer


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: migraine


subject: CHEBI:53760

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Advanced Hodgkin Lymphoma


subject: CHEBI:64816


subject: UMLS:C5565806

object_name: Hepatic impairment


subject: CHEBI:34945

object_name: Chronic constipation


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UNII:V9GGV0YCDI

object_name: Refractory acute myeloid leukemia


subject: UNII:V9GGV0YCDI

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:V9GGV0YCDI

object_name: Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia


subject: UNII:V9GGV0YCDI

object_name: Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia


subject: UNII:V9GGV0YCDI

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:V9GGV0YCDI

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:V9GGV0YCDI

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:V9GGV0YCDI

object_name: myelodysplastic syndrome with excess blasts


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: lung cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:3844471

object_name: lung carcinoma


subject: CHEBI:176724

subject_name: Etiracetam

object_name: glioblastoma


subject: CHEBI:176724

object_name: Brain Stem Glioblastoma


subject: CHEBI:176724

object_name: glioma susceptibility 1


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:36791

subject_name: Escitalopram

object_name: periampullary adenocarcinoma


subject: CHEBI:36791

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:83766

subject_name: Olaparib

object_name: adrenal gland neoplasm


subject: CHEBI:83766

object_name: High Risk Neuroblastoma


subject: CHEBI:83766

object_name: adrenal gland pheochromocytoma


subject: CHEBI:83766

object_name: pheochromocytoma


subject: CHEBI:83766

object_name: medulloblastoma


subject: CHEBI:83766

object_name: childhood medulloblastoma


subject: CHEBI:83766

object_name: adult medulloblastoma


subject: CHEBI:83766

object_name: paraganglioma


subject: CHEBI:83766

object_name: Adult Meningioma


subject: CHEBI:83766

object_name: benign meningioma


subject: CHEBI:83766

object_name: familial meningioma


subject: CHEBI:83766

object_name: pediatric meningioma


subject: CHEBI:83766

object_name: meningioma


subject: UNII:MRL3739G66

subject_name: Dotatate


subject: UNII:MRL3739G66


subject: UMLS:C4733468

subject_name: CriPec® docetaxel

object_name: Childhood Solid Neoplasm


subject: UMLS:C4733468

object_name: Adult Solid Neoplasm


subject: UMLS:C5575682

subject_name: Kefir antigen

object_name: diarrhea


subject: UMLS:C5575682

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C5575682

object_name: Diarrhea, CTCAE


subject: UMLS:C5575682

object_name: Clostridium difficile colitis


subject: UMLS:C5575682

object_name: clostridium difficile infection


subject: MESH:D008458

subject_name: Measles Vaccine

object_name: Immunotoxicity


subject: MESH:D009108

subject_name: Mumps Vaccine


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: microinvasive gastric cancer


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:4466

object_name: Embolism, Tumor


subject: CHEBI:4466

object_name: Neoplasm Metastasis


subject: CHEBI:4466

object_name: Pain, Intractable


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:45716

subject_name: Vorinostat

object_name: cancer


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: moderately severe hemophilia A


subject: UMLS:C5556545

subject_name: Esomeprazole Topical Cream

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate

object_name: respiratory failure


subject: PUBCHEM.COMPOUND:23431961

object_name: bronchopulmonary dysplasia


subject: PUBCHEM.COMPOUND:23431961

object_name: Respiratory insufficiency


subject: PUBCHEM.COMPOUND:23431961

object_name: congenital heart disease


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:34969

subject_name: Crinecerfont

object_name: adrenogenital syndrome


subject: CHEBI:34969

object_name: congenital adrenal hyperplasia


subject: CHEBI:174615

object_name: acute myeloid leukemia/transient myeloproliferative disorder


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:7773

subject_name: Ondansetron

object_name: small intestine cancer


subject: CHEBI:7773

object_name: small intestine carcinoma


subject: CHEBI:7773

object_name: precancerous condition


subject: CHEBI:7773

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:O0408QB48D

subject_name: Chlorsulfaquinoxaline

object_name: lung cancer


subject: UNII:O0408QB48D

object_name: lung neoplasm


subject: UNII:O0408QB48D

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:73012857


subject: PUBCHEM.COMPOUND:73012857


subject: PUBCHEM.COMPOUND:73012857


subject: UNII:UG7I3Y42PV

subject_name: Fluoroazomycin arabinoside F-18

object_name: advanced disease


subject: UNII:UG7I3Y42PV

object_name: pancreatic adenocarcinoma


subject: UNII:UG7I3Y42PV

object_name: metastatic neoplasm


subject: UNII:UG7I3Y42PV

object_name: Embolism, Tumor


subject: UNII:UG7I3Y42PV

object_name: Neoplasm Metastasis


subject: UNII:UG7I3Y42PV

object_name: Metastatic Lesion


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: small bowel Crohn disease


subject: UMLS:C4688492

object_name: Compulsion


subject: CHEBI:41039

subject_name: benfotiamine

object_name: type 1 diabetes mellitus 1


subject: CHEBI:41039

object_name: type 1 diabetes mellitus


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Hormone receptor negative HER2 positive breast cancer


subject: CHEBI:6413

subject_name: Letrozole


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UNII:16VY3TM7ZO

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: CHEBI:95341

subject_name: Baricitinib

object_name: neuromyelitis optica


subject: CHEBI:2948

subject_name: Azathioprine

object_name: myasthenia gravis


subject: CHEBI:2948

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:6402

subject_name: Leflunomide


subject: CHEBI:6402


subject: UMLS:C5555578

object_name: colorectal cancer


subject: UMLS:C5555578

object_name: colorectal carcinoma


subject: UMLS:C5555578

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Pathologic fracture


subject: UNII:4EQZ6YO2HI

object_name: Refractory Neoplasm


subject: UNII:4EQZ6YO2HI

object_name: Recurrent disease


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: neoplasm of cardioesophageal junction


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Gastric Carcinoma


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Plexosarcoma


subject: CHEBI:31348

object_name: Childhood Gastrointestinal Stromal Tumor


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: UNII:AHI9T7EDX6

subject_name: Pneumovax 23

object_name: influenza


subject: RXCUI:287523


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: peripheral nervous system disorder


subject: UMLS:C0358855

object_name: neuropathy


subject: UMLS:C0358855

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: UMLS:C0358855

object_name: neuralgia


subject: UMLS:C0358855

object_name: Neuropathic pain


subject: CHEMBL.COMPOUND:CHEMBL4297251

subject_name: ORANGE JUICE

object_name: Vascular Stiffness


subject: MESH:C521519

subject_name: MVAp53 vaccine

object_name: Recurrent ovarian cancer


subject: MESH:C521519

object_name: Recurrent Fallopian Tube Carcinoma


subject: MESH:C521519

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:BKV67W3IO8

subject_name: Cesium Cs-131

object_name: Recurrent Head and Neck Carcinoma


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Unresectable Salivary Gland Carcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Metastatic Salivary Gland Carcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Salivary Gland Cancer


subject: PUBCHEM.COMPOUND:121489720

object_name: Locally Advanced Salivary Gland Carcinoma


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6427


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: amnesia


subject: CHEBI:6367

object_name: Memory Impairment, CTCAE 5.0


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Hematoma of rectus sheath


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)

object_name: adverse effect


subject: UMLS:C3248676

object_name: Adverse effects


subject: UMLS:C3248676

object_name: Adverse reactions


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:167282486

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:167282486

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5556420

subject_name: BTK Degrader NX-2127


subject: UMLS:C5556420


subject: CHEBI:41423

subject_name: Celecoxib

object_name: preeclampsia


subject: CHEBI:79042

subject_name: Tasimelteon

object_name: Hepatic impairment


subject: CHEBI:41264

subject_name: butyl group

object_name: plasma cell myeloma


subject: UMLS:C0733688


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Dyslipidemia due to type 2 diabetes mellitus


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: prostate carcinoma


subject: CHEBI:35457

object_name: prostate cancer


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:87631


subject: CHEBI:63660


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:84363

object_name: glucose metabolism disease


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: leukoplakia


subject: CHEBI:17549

object_name: erythroplakia


subject: CHEBI:72296

subject_name: Apixaban

object_name: Thrombosis of vein of upper limb


subject: CHEBI:72296

object_name: Upper Extremity Deep Vein Thrombosis, Secondary


subject: CHEBI:38940

subject_name: Sunitinib

object_name: nasopharyngeal carcinoma


subject: CHEBI:38940

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:51368

subject_name: Lofexidine

object_name: post-traumatic stress disorder


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: schizophrenia


subject: CHEBI:65353

object_name: schizoaffective disorder


subject: CHEBI:65353

object_name: schizophrenia 18


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: keratopathy


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: metastatic colorectal cancer


subject: CHEBI:15698

object_name: Microsatellite Stable Colorectal Carcinoma


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: PR:000014340

subject_name: regulator of telomere elongation helicase 1

object_name: lymphoma, non-Hodgkin, familial


subject: PR:000014340

object_name: non-Hodgkin lymphoma


subject: UMLS:C5555198

subject_name: Anti-STn Antibody-drug Conjugate SGN-STNV

object_name: endometrium neoplasm


subject: UMLS:C5555198

object_name: Gastroesophageal Junction Carcinoma


subject: UMLS:C5555198

object_name: non-small cell lung carcinoma


subject: UMLS:C5555198

object_name: cervical polyp


subject: UMLS:C5555198

object_name: appendix adenocarcinoma


subject: UMLS:C5555198

object_name: pseudomyxoma peritonei


subject: UMLS:C5555198

object_name: neoplasm of esophagus


subject: UMLS:C5555198

object_name: colorectal neoplasm


subject: UMLS:C5555198

object_name: ovarian cancer


subject: UMLS:C5555198

object_name: ovarian neoplasm


subject: UMLS:C5555198

object_name: gastric neoplasm


subject: CHEBI:76842

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:76842

object_name: adverse effect


subject: CHEBI:76842

object_name: Adverse effects


subject: CHEBI:76842

object_name: Adverse reactions


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: UNII:I3P1L0D47K

subject_name: creatine ethyl ester

object_name: acute kidney failure


subject: UNII:I3P1L0D47K


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate


subject: UNII:9603LN7R2Q


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:16919


subject: CHEBI:15859

subject_name: N-Carbamoylaspartic acid

object_name: Overweight


subject: CHEBI:15859

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:15859

object_name: obesity


subject: CHEBI:15859

object_name: Obesity, CTCAE


subject: UMLS:C5556439

subject_name: Vilamakitug

object_name: metastatic colorectal cancer


subject: CHEBI:3757

subject_name: Clonidine

object_name: Intrusive memories


subject: CHEBI:10093

subject_name: Yohimbine


subject: UMLS:C4331423

subject_name: Traditional Chinese Medicine Formulation


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:50949

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C0360105


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C2911696


subject: UMLS:C0003290

subject_name: Tricyclic Antidepressive Agents


subject: UMLS:C0003290


subject: UMLS:C0003290

object_name: Depressed mood


subject: UMLS:C0003290

object_name: Cancer patients and suicide and depression


subject: UMLS:C0003290

object_name: Depressed - symptom


subject: UMLS:C0003290

object_name: Depression, CTCAE


subject: CHEBI:30956

subject_name: trichloroacetic acid


subject: CHEBI:30956


subject: CHEBI:30956


subject: CHEBI:30956


subject: CHEBI:30956


subject: CHEBI:30956


subject: UMLS:C3536819

subject_name: Tricyclic Antidepressant [EPC]


subject: UMLS:C3536819


subject: UMLS:C3536819


subject: UMLS:C3536819


subject: UMLS:C3536819


subject: UMLS:C3536819


subject: CHEBI:80343

subject_name: Mecasermin

object_name: disease of bone structure


subject: PUBCHEM.COMPOUND:75988815

subject_name: Elafibranor

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:75988815

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:75988815

object_name: liver disorder


subject: UMLS:C1529682

object_name: Childhood Neuroblastoma


subject: UMLS:C1529682

object_name: neuroblastoma


subject: UMLS:C1529682

object_name: pediatric osteosarcoma


subject: UMLS:C1529682

object_name: Osteosarcoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: carcinoid syndrome


subject: CHEBI:7459

subject_name: Naloxone

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:66980

subject_name: nootropic agent

object_name: mood (physical finding)


subject: UMLS:C0242913

subject_name: Nootropic Agents


subject: UNII:19FUJ2C58T

subject_name: Ginkgo biloba


subject: UMLS:C3531686

subject_name: Ginkgo biloba whole extract


subject: CHEBI:31902

subject_name: Nicergoline


subject: CHEBI:32010

subject_name: Piracetam


subject: UMLS:C0125069

subject_name: L-ornithine L-aspartate

object_name: Childhood Breast Carcinoma


subject: UMLS:C0125069

object_name: breast carcinoma


subject: UMLS:C0125069

object_name: breast cancer


subject: CHEBI:136519

subject_name: n-butyl isocyanate

object_name: AIDS


subject: PUBCHEM.COMPOUND:21130

subject_name: imidazole mustard


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: Renal Failure, CTCAE


subject: CHEBI:144421

subject_name: ferric citrate


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:9824461

object_name: coronary atherosclerosis


subject: CHEBI:28243

subject_name: Octacosanol

object_name: Increased reactive oxygen species production


subject: CHEBI:28243

object_name: Dyslipidemia


subject: CHEBI:94782

subject_name: Cediranib

object_name: brain neoplasm


subject: UNII:T1JP1KYU9O

subject_name: Flortaucipir F-18

object_name: Pick Complex


subject: UNII:T1JP1KYU9O

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:T1JP1KYU9O

object_name: frontotemporal dementia


subject: UNII:T1JP1KYU9O

object_name: Pick disease


subject: UMLS:C1704241

subject_name: complex (molecular entity)


subject: UMLS:C1704241

object_name: Psychological Distress


subject: CHEBI:64312

subject_name: Memantine

object_name: delirium


subject: CHEBI:64312

object_name: Delirium, CTCAE


subject: PUBCHEM.COMPOUND:66586232

object_name: Oral ulcer


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Myelodysplasia


subject: CHEBI:38940

object_name: Secondary Myelodysplastic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID

object_name: meningococcal meningitis


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: meningococcal infection


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: meningitis


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: Meningitis, CTCAE


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C0982332


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEMBL.COMPOUND:CHEMBL4802178

object_name: type 2 diabetes mellitus


subject: UMLS:C3254521


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C3898587

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C3898587

object_name: sarcoma


subject: UMLS:C3898587

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C3898587

object_name: soft tissue sarcoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C4725696

object_name: Childhood Solid Neoplasm


subject: UMLS:C4725696

object_name: Adult Solid Neoplasm


subject: UMLS:C4725696

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:382513

subject_name: Aclacinomycin X


subject: PUBCHEM.COMPOUND:382513

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:382513

object_name: myoclonic dystonia 11


subject: PUBCHEM.COMPOUND:152864

subject_name: Aclacinomycin Y

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:152864


subject: PUBCHEM.COMPOUND:152864


subject: DRUGBANK:DB19070

subject_name: Aklavine


subject: DRUGBANK:DB19070


subject: DRUGBANK:DB19070


subject: CHEBI:74619

subject_name: Aclarubicin


subject: CHEBI:74619


subject: CHEBI:74619


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Malignant lymphoid neoplasm


subject: UMLS:C1831992

subject_name: ABT 263


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: pancreatic neoplasm


subject: UMLS:C0728976

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0728976

object_name: malignant pancreatic neoplasm


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: CHEBI:16919

subject_name: Creatine

object_name: rheumatoid arthritis


subject: CHEBI:188986

subject_name: idose

object_name: angle-closure glaucoma


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG

object_name: Cholangiocarcinoma resectable


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: cancer


subject: CHEBI:100241

object_name: neoplasm


subject: CHEBI:100241

object_name: leukopenia


subject: CHEBI:100241

object_name: neutropenia


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: CHEBI:51254

object_name: Fever


subject: CHEBI:51254

object_name: Fever symptoms (finding)


subject: CHEBI:51254

object_name: Fever, CTCAE


subject: CHEBI:51254


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:49603

subject_name: Lapatinib

object_name: carcinoma


subject: UMLS:C5785437

subject_name: TLR7 Agonist CAN1012

object_name: Childhood Solid Neoplasm


subject: UMLS:C5785437

object_name: Adult Solid Neoplasm


subject: UMLS:C5785437

object_name: Solid Neoplasm


subject: UMLS:C2355530

subject_name: CRx 102

object_name: osteoarthritis, knee


subject: CHEBI:9605

subject_name: Tirofiban

object_name: myocardial infarction


subject: CHEBI:9605

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:9605

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:9605

object_name: angina unstable


subject: UNII:IKE1P4X57J

subject_name: Aggrastat


subject: UNII:IKE1P4X57J


subject: UNII:IKE1P4X57J


subject: UNII:IKE1P4X57J

object_name: acute coronary syndrome


subject: UNII:IKE1P4X57J


subject: CHEBI:38867

subject_name: anaesthetic

object_name: Consciousness Disorders


subject: UMLS:C0002932

subject_name: Anesthetics


subject: UMLS:C4722058

subject_name: Anesthetics [TC]


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: neuroendocrine neoplasm


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:125427

object_name: asthma


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: UMLS:C3539963

subject_name: Amide local anesthetic combinations

object_name: Transfusion dependent thalassaemia


subject: UMLS:C3539976

subject_name: Penicillins with extended spectrum combinations


subject: UMLS:C3540719


subject: UMLS:C3539181

subject_name: Short-acting sulfonamide combinations


subject: UMLS:C3540722

subject_name: Beta-lactamase sensitive penicillin combinations


subject: UMLS:C3539959

subject_name: Long-acting sulfonamide combinations


subject: UMLS:C3539969

subject_name: Specific immunoglobulin combinations


subject: UMLS:C3540031

subject_name: gonadotropin combinations


subject: UMLS:C3540026

subject_name: Hepatitis vaccine combinations


subject: UMLS:C3539182

subject_name: Salt solution combinations


subject: UMLS:C3539955

subject_name: lung surfactant combinations


subject: UMLS:C3539956

subject_name: Magnesium antacid compound combinations


subject: UMLS:C3539957

subject_name: opium alkaloids and derivative combination cough suppressants


subject: UMLS:C3539960

subject_name: Other intestinal adsorbent combinations in ATC


subject: UMLS:C3539961

subject_name: Platelet aggregation inhibitor combinations excl. heparin


subject: UMLS:C3539962

subject_name: vitamin D and analog combinations


subject: UMLS:C3539964

subject_name: local opthalmologic anesthetic combinations


subject: UMLS:C3539965

subject_name: Local hemostatic combinations


subject: UMLS:C3539966

subject_name: insulins and analogs for injection combinations, long-acting


subject: UMLS:C3539967

subject_name: Insulins and analogs for injection, intermediate-acting combined with fast-acting- combinations


subject: UMLS:C3539968

subject_name: Enema combinations


subject: UMLS:C3539970

subject_name: combination drugs used in erectile dysfunction


subject: UMLS:C3539971

subject_name: otologic analgesic and anesthetic combinations


subject: UMLS:C3539972

subject_name: Combination solutions for parenteral nutrition


subject: UMLS:C3539973

subject_name: Other antifungal combinations for topical use in ATC


subject: UMLS:C3539974

subject_name: Insulins and analogs for injection, intermediate-acting combinations


subject: UMLS:C3539975

subject_name: Aluminium antacid compound combinations


subject: UMLS:C3539977

subject_name: Calcium antacid compound combinations


subject: UMLS:C3539978

subject_name: expectorant combinations excluding combinations with cough suppressants


subject: UMLS:C3539979

subject_name: Antiinfective irrigating solution combinations


subject: UMLS:C3540027

subject_name: Adrenergic and dopaminergic agents combinations


subject: UMLS:C3540028

subject_name: Other irrigating solution combinations in ATC


subject: UMLS:C3540030

subject_name: other cough suppressant combinations in ATC


subject: UMLS:C3540720

subject_name: Caries prophylactic agent combinations


subject: UMLS:C3540721

subject_name: other nasal preparation combinations in ATC


subject: UMLS:C3540723

subject_name: Insulins and analogs for injection, fast-acting combinations


subject: UMLS:C3540724

subject_name: expectorant combinations, excl. combinations with cough suppressants


subject: UMLS:C3854036

subject_name: Other anti-dementia drug combinations in ATC


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: UMLS:C2348678

subject_name: Flavanol

object_name: cardiovascular disorder


subject: CHEBI:48991


subject: PUBCHEM.COMPOUND:11147906

subject_name: methylxanthine


subject: CHEBI:25348


subject: UMLS:C3536939

subject_name: Methylxanthine [EPC]


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: adult acute respiratory distress syndrome


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:18248

subject_name: Iron

object_name: hereditary endocrine growth disease


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:27470

subject_name: Folic acid


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: malnutrition


subject: DRUGBANK:DB17475


subject: CHEBI:137262

subject_name: Leu-Asn-Ser

object_name: anemia


subject: CHEBI:137262

object_name: Anemia, CTCAE


subject: CHEBI:24433

subject_name: group


subject: CHEBI:24433


subject: CHEBI:24433


subject: UMLS:C0351302

subject_name: sodium salts

object_name: amyotrophic lateral sclerosis


subject: CHEBI:26714

subject_name: sodium salt


subject: CHEBI:57694

object_name: Heartburn


subject: CHEBI:57694

object_name: Reflux


subject: CHEBI:57694

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: UNII:AH2E5UQ11Y

object_name: anxiety


subject: UNII:AH2E5UQ11Y

object_name: anxiety disorder


subject: UNII:AH2E5UQ11Y

object_name: Anxiety symptoms


subject: UNII:AH2E5UQ11Y

object_name: Anxiety, CTCAE 3.0


subject: UNII:AH2E5UQ11Y

object_name: Anxiety, CTCAE 5.0


subject: UNII:AH2E5UQ11Y

object_name: Depressed mood


subject: CHEBI:33380

subject_name: thulium atom

object_name: Alzheimer disease 2


subject: CHEBI:33380

object_name: Alzheimer Disease, Late Onset


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: UMLS:C5203423

subject_name: Nivolumab Liquid Injection

object_name: cervical cancer


subject: UMLS:C5203423

object_name: cervical carcinoma


subject: CHEBI:7507

subject_name: Framycetin

object_name: biliary atresia


subject: CHEBI:6942

subject_name: Minoxidil

object_name: Williams syndrome


subject: CHEBI:83766

subject_name: Olaparib

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:83766

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Well adult


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:9241

subject_name: Spironolactone

object_name: cardiotoxicity


subject: CHEBI:9241

object_name: Effects of chemotherapy


subject: CHEBI:231683

subject_name: Anakinra

object_name: Anterior Cruciate Ligament Tear


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UMLS:C1138626

subject_name: cocoa extract

object_name: Increased reactive oxygen species production


subject: UMLS:C1138626

object_name: Overweight and obesity


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: DRUGBANK:DB10977


subject: PR:000004970

subject_name: calcium-binding and coiled-coil domain-containing protein 1


subject: PR:000004970


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: UMLS:C0939909


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER


subject: CHEMBL.COMPOUND:CHEMBL2108465


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:C5529G5JPQ


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: preeclampsia


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:233436

subject_name: Tolebrutinib

object_name: primary progressive multiple sclerosis


subject: DRUGBANK:DB18715


subject: CHEBI:135966

subject_name: Carisbamate

object_name: Lennox-Gastaut syndrome


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Low Back Pain, Mechanical


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: Fatty Liver


subject: CHEMBL.COMPOUND:CHEMBL5314341

object_name: Cirrhosis


subject: CHEMBL.COMPOUND:CHEMBL5314341

object_name: liver cirrhosis


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:5391


subject: CHEBI:5391


subject: CHEBI:5062

subject_name: Finasteride

object_name: prostate intraepithelial neoplasia


subject: CHEBI:5132

subject_name: Flutamide


subject: CHEBI:48510

subject_name: triflate group

object_name: vitamin D deficiency


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: corneal disease


subject: UMLS:C0017132

subject_name: Gastric Inhibitory Polypeptide

object_name: Diabetes


subject: CHEBI:80165


subject: CHEBI:80165

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:44216444

subject_name: xenin


subject: PUBCHEM.COMPOUND:44216444


subject: UMLS:C0527368

subject_name: xenin 25


subject: UMLS:C0527368


subject: MESH:C000710692

object_name: Pick Complex